tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NUVL Stock Latest News

Nuvalent files automatic mixed securities shelf
The FlyNuvalent files automatic mixed securities shelf
18d ago
NUVL
Nuvalent price target lowered to $145 from $147 at JPMorgan
PremiumThe Fly
Nuvalent price target lowered to $145 from $147 at JPMorgan
21d ago
NUVL
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today, 12/18/2025, According to Top Analysts
22d ago
FHTX
NUVL
Nuvalent’s Royalty Interest Acquired by Royalty Pharma
PremiumCompany Announcements
Nuvalent’s Royalty Interest Acquired by Royalty Pharma
24d ago
8K
NUVL
Royalty Pharma acquires royalty interest in Nuvalent’s neladalkib, zidesamtinib
PremiumThe Fly
Royalty Pharma acquires royalty interest in Nuvalent’s neladalkib, zidesamtinib
24d ago
NUVL
RPRX
Ron Squarer Joins Nuvalent Board as Independent Director
PremiumCompany AnnouncementsRon Squarer Joins Nuvalent Board as Independent Director
1M ago
8K
NUVL
Nuvalent initiated with a Buy at Truist
Premium
The Fly
Nuvalent initiated with a Buy at Truist
2M ago
NUVL
Nuvalent Announces $500M Stock Offering Pricing
Premium
Company Announcements
Nuvalent Announces $500M Stock Offering Pricing
2M ago
8K
NUVL
Nuvalent’s New Drug Application for zidesamtinib in NSCLC acepted by FDA
PremiumThe Fly
Nuvalent’s New Drug Application for zidesamtinib in NSCLC acepted by FDA
2M ago
NUVL
Nuvalent 4.95M share Secondary priced at $101.00
PremiumThe Fly
Nuvalent 4.95M share Secondary priced at $101.00
2M ago
NUVL
Nuvalent price target raised to $135 from $120 at Goldman Sachs
PremiumThe Fly
Nuvalent price target raised to $135 from $120 at Goldman Sachs
2M ago
NUVL
Nuvalent price target raised to $155 from $125 at Guggenheim
PremiumThe Fly
Nuvalent price target raised to $155 from $125 at Guggenheim
2M ago
NUVL
Nuvalent price target raised to $158 from $112 at Baird
PremiumThe FlyNuvalent price target raised to $158 from $112 at Baird
2M ago
NUVL
Nuvalent’s Neladalkib Shows Superior Efficacy and Safety in Clinical Trials
Premium
Ratings
Nuvalent’s Neladalkib Shows Superior Efficacy and Safety in Clinical Trials
2M ago
NUVL
Nuvalent announces $500M Class A common stock offering
Premium
The Fly
Nuvalent announces $500M Class A common stock offering
2M ago
NUVL
Nuvalent price target raised to $152 from $112 at Barclays
PremiumThe Fly
Nuvalent price target raised to $152 from $112 at Barclays
2M ago
NUVL
Nuvalent rises 15.8%
PremiumThe Fly
Nuvalent rises 15.8%
2M ago
NUVL
Nuvalent price target raised to $135 from $115 at Stifel
PremiumThe Fly
Nuvalent price target raised to $135 from $115 at Stifel
2M ago
NUVL
Nuvalent price target raised to $149 from $140 at Leerink
PremiumThe Fly
Nuvalent price target raised to $149 from $140 at Leerink
2M ago
NUVL
Nuvalent’s Neladalkib: Promising ALK+ NSCLC Treatment with Strong Phase 2 Data and De-risked Approval Path
PremiumRatingsNuvalent’s Neladalkib: Promising ALK+ NSCLC Treatment with Strong Phase 2 Data and De-risked Approval Path
2M ago
NUVL
Nuvalent’s Promising Future: Buy Rating Backed by ALKOVE-1 Study Success and Strategic Growth Plans
Premium
Ratings
Nuvalent’s Promising Future: Buy Rating Backed by ALKOVE-1 Study Success and Strategic Growth Plans
2M ago
NUVL
Nuvalent price target raised to $155 from $130 at H.C. Wainwright
Premium
The Fly
Nuvalent price target raised to $155 from $130 at H.C. Wainwright
2M ago
NUVL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >